The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
CONCLUSION: This is the first study to examine treatment effects on the microbiome in BAD, which demonstrated a possible association with colesevelam on the microbiome through bile acid modulation in clinical responders. Larger studies are now needed to establish a causal relationship with colesevelam and the inter-crosstalk between bile acids and the microbiome.PMID:37007510 | PMC:PMC10063896 | DOI:10.3389/fmicb.2023.1134105
Source: Cancer Control - Category: Cancer & Oncology Authors: Aditi Kumar Mohammed Nabil Quraishi Hafid O Al-Hassi Mohammed E El-Asrag Jonathan P Segal Manushri Jain Helen Steed Jeffrey Butterworth Adam Farmer John Mclaughlin Andrew Beggs Matthew J Brookes Source Type: research
More News: Bile | Cancer | Cancer & Oncology | Cholecystectomy | Crohn's Disease | Diarrhoea | Genetics | Inflammatory Bowel Disease | Selenium | Study | Welchol